How i-FACTOR Bone Graft Compares to Other Bone Grafts

At Cerapedics, we are focused on developing and commercializing novel osteobiologic products based on a proprietary small peptide technology (P-15) on anorganic bone mineral (ABM), supported by the highest level of clinical evidence, and validated in clinically relevant real world applications.

In the lecture presentation “Bone Grafting Options & Evidence”, company President and COO Jeff Marx analyzes the market for bone void fillers and bone graft substitutes. Dr. Marx uses the broader bone grafting market to introduce i-FACTOR Bone Graft and explain why it is a novel and advanced biologic.

For additional information on the world of bone grafts and what sets i-FACTOR Bone Graft apart, Explore Here.